Santa Clara, California
October 8, 2008
Centre for Proteomic and
Genomic Research aims to become the country's hub for
microarray-based research
Affymetrix Inc.
(Nasdaq:AFFX) today announced that one of South Africa's largest
public core labs has begun offering genomic research on the
Affymetrix GeneChip(R) platform.
The Centre for Proteomic and
Genomic Research (CPGR) is using many Affymetrix GeneChip
arrays, such as the exon array and the SNP Array 6.0, to explore
applications with molecular diagnostics potential, large-scale
genotyping and novel ways of advancing drug research and
development across the country.
The CPGR supports scientists particularly in biomedicine and
plant biotechnology. It has a particular interest in
translational research, advancing scientific findings from the
bench into the clinic. The Centre was founded in 2006 to provide
state-of-the-art analytical services, technical expertise,
project support and collaborative research capabilities in
genomics and proteomics.
"At the CPGR, our aim is to facilitate high-quality research and
enable the growth of existing southern African biotech
companies," said Reinhard Hiller, Ph.D., managing director of
the CPGR. "The range of projects we work on is particularly
diverse, so we appreciate the ability of Affymetrix to offer
products that meet all our customers' needs, from toxicology to
gene expression and genotyping."
"The CPGR has assembled a team of world-class scientists to
nourish the development of new biotech leaders by translating
academic research into novel intellectual property and
commercial ventures," said Kevin King, president of Affymetrix.
"With its adoption of the entire portfolio of array products
available on our integrated microarray platform, the Centre is
setting new standards for microarray-based research which we
believe will lead to important solutions for some of the
region's most pressing diseases."
Affymetrix GeneChip(R) microarray technology is the
industry-standard tool for analyzing complex genetic
information. After inventing microarray technology in the late
1980s, Affymetrix scientists have been dedicated to developing
innovative products that provide researchers with a more
complete view of the genome. These products continue to
accelerate genetic research and enable scientists to develop
diagnostics and tailor treatments for individual patients by
identifying and measuring the genetic information associated
with complex diseases.
Today, Affymetrix technology is used by the world's top
pharmaceutical, diagnostic and biotechnology companies, as well
as leading academic, government and not-for-profit research
institutes. More than 1,700 systems have been shipped around the
world and more than 13,000 peer-reviewed papers have been
published using the technology.
Affymetrix is headquartered in Santa Clara, Calif., and has
manufacturing facilities in Sacramento, Calif., Cleveland, Ohio,
and Singapore. The company has about 1,100 employees worldwide
and maintains sales and distribution operations across Europe
and Asia. For more information about Affymetrix, please visit
the company's website at
www.affymetrix.com.
The Centre for Proteomic & Genomic Research (CPGR) is an
integrated core technology facility, founded in South Africa in
2006 as a not-for-profit organization through a grant provided
by the Department of Science and Technology (DST) by way of its
vehicles the Cape Biotech Trust CBT) and PlantBio (PB). Visit
www.cpgr.org.za for more
information or contact info@cpgr.org.za with specific requests.
Affymetrix, the Affymetrix logo and GeneChip(R) are registered
trademarks owned or used by Affymetrix Inc. |
|